Shire plc : Director/PDMR Shareholding
August 09, 2017 09:16 ET
|
Shire Pharmaceuticals Group
Director/PDMR Shareholding August 9, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transaction by person discharging managerial responsibilities and person closely associated with them ...
Shire plc : Half-yearly report
August 04, 2017 02:51 ET
|
Shire Pharmaceuticals Group
Half-yearly Report August 4, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), ("Shire" / the "Group") in accordance with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules, is...
Shire plc : Shire reports strong Q2 2017 operating results and cash flow
August 03, 2017 07:02 ET
|
Shire Pharmaceuticals Group
Shire reports strong Q2 2017 operating results and cash flow; updates full year guidance Q2 product sales growth of 7% on a combined pro forma basis; generated $1.2 billion operating cash flow ...
Shire plc : Total voting rights
August 01, 2017 07:01 ET
|
Shire Pharmaceuticals Group
Total Voting Rights August 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and...
Gap In Perceived and Actual Rates Of Prescription Stimulant Misuse, Abuse and Diversion Found Among College Students
July 26, 2017 07:00 ET
|
Shire Pharmaceuticals Group
Gap In Perceived and Actual Rates Of Prescription Stimulant Misuse, Abuse and Diversion Found Among College Students Preliminary analysis of data shows association between non-medical use of...
Shire Expands Broad Monoclonal Antibody Research Platform, Enters License Agreement for Novimmune Bi-specific Antibody
July 18, 2017 07:01 ET
|
Shire Pharmaceuticals Group
Shire Expands Broad Monoclonal Antibody Research Platform, Enters License Agreement for Novimmune Bi-specific Antibody Shire obtains worldwide license to pursue development and...
Shire plc : Notice of Results
July 18, 2017 07:01 ET
|
Shire Pharmaceuticals Group
Shire to announce second quarter 2017 results Dublin, Ireland - July 18, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG), will announce second quarter 2017 earnings on Thursday August 3, 2017. ...
Shire submits investigational New Drug Application to FDA for Gene Therapy candidate SHP654 for treatment of Hemophilia A
July 06, 2017 07:00 ET
|
Shire Pharmaceuticals Group
Shire submits investigational New Drug Application to FDA for Gene Therapy candidate SHP654 for treatment of Hemophilia A SHP654 aims to deliver sustained protection against bleeds for...
Shire plc : Additional Listing
July 06, 2017 02:01 ET
|
Shire Pharmaceuticals Group
Additional Listing July 6, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") hereby notifies the market that an application has been made to the London Stock Exchange and the UK Listing...
Shire plc : Director/PDMR Shareholding
July 03, 2017 08:31 ET
|
Shire Pharmaceuticals Group
Director/PDMR Shareholding July 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging...